Company profile: Andrew Alliance
1.1 - Company Overview
Company description
- Provider of robotics and software for Life Sciences, including Andrew+ pipetting robot for automated liquid handling; OneLab browser-based software to design, execute and share laboratory protocols with full traceability and error reduction; Pipette+ smart electronic pipettes; Extraction+ automated SPE system; Heater-Shaker+ for mixing and temperature control; and Shaker+ orbital shaker connected to OneLab.
Products and services
- OneLab: A browser-based platform that allows scientists to develop, execute, and share laboratory protocols, delivering full traceability and error reduction throughout experimental workflows
- Andrew+: An industrial-grade pipetting robot that automates liquid handling using electronic pipettes and labware holders, enabling reproducible and traceable experiments
- Pipette+: Browser-controlled smart electronic pipettes that automate settings to enhance manual pipetting, producing full traceability of operations.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Andrew Alliance
Zellkraftwerk
HQ: Germany
Website
- Description: Provider of complete workflow solutions, offering both products and research services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zellkraftwerk company profile →
Protedyne
HQ: United States
Website
- Description: Provider of laboratory automation systems that integrate powerful laboratory robotic hardware and industrial automation design principles, bringing serious laboratory automation to LabCorp's diagnostic testing facilities nationwide and supporting existing pharmaceutical, biotech, and diagnostic testing customers as a wholly owned subsidiary of Laboratory Corporation of America.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Protedyne company profile →
Immunicom
HQ: United States
Website
- Description: Provider of patented Immunopheresis blood-filtering technology that removes specific blood factors to enable the immune system to fight certain cancers; the LW-02 investigational therapeutic cartridge; the EN-06 cartridge in pre-clinical development; and clinical trials at leading hospitals evaluating LW-02 for triple-negative breast cancer, non-small cell lung cancer, melanoma, and renal cell carcinoma.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunicom company profile →
Mobilion Systems
HQ: United States
Website
- Description: Provider of high-resolution ion mobility mass spectrometry and targeted molecular analyses to identify and analyze challenging molecules that other instruments so far have failed to detect. Offers MOBIE for rapid, high-resolution separation and identification, plus targeted lipidomics, targeted proteomics, glycomics, metabolomics, and therapeutic oligonucleotide analysis for disease research, diagnostics, biomarker discovery, and therapeutic development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mobilion Systems company profile →
Accuri Cytometers
HQ: United States
Website
- Description: Provider of cost-effective flow cytometers for laboratory use, designed to deliver rapid cell-by-cell analysis while reducing barriers for researchers, including instrument cost, software complexity, and maintenance effort.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Accuri Cytometers company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Andrew Alliance
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Andrew Alliance
2.2 - Growth funds investing in similar companies to Andrew Alliance
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Andrew Alliance
4.2 - Public trading comparable groups for Andrew Alliance
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →